top of page

2019 NCAP

Chronic Care & Health-System Conference

Services
February 28
- March 1
The Rizzo Conference Center, Chapel Hill

This may be the first time you attend a conference and don't want to leave. The Rizzo is that good!

Hotel rooms feature premium bedding for a rejuvenating night's sleep. Modern style bathrooms have a luxury boutique feel. Large windows that open provide plenty of fresh air, natural light, and views of the beautiful estate landscaping. Sit back and relax in comfortable accommodations, or take advantage of top-of-the-line technology to get some work done which includes data ports, WiFi, and TVs with laptop access. Late night snack attack? Every floor has a guest pantry stocked with snacks, frozen treats, refreshing beverages and coffee and tea stations. An electronic safe, iron & ironing board are included.  24-hour fitness facilities, bar/lounge, pool table, and outdoor games on site. Facility and grounds are ADA accessible. Free breakfast included with your overnight stay.

Book your room soon so you don't miss out.

Exhibitor Information

Thursday, February 28th

Exhibitor Sessions:

 

12:00 - 2:00 pm Reverse Showcase Roundtables with Decision Makers

2:30 - 3:30 pm  Product Roundtables with Conference Attendees

4:30 - 5:30 pm  Networking with Exhibitors Reception

​

​

​

Space is limited and the format is a hassle-free event.  There will be no booth set up, and no need to ship or bring a display; all exhibitor sessions are to be small group roundtables or one-on-one interactions.

​

Click here for Exhibitor Registration

Contact Rhonda Horner-Davis at rhonda@ncpharmacists.org or 336-266-8784

SCHEDULE-AT-A-GLANCE

Thursday, February 28th

7:30-8:15am    Breakfast and Registration

8:15-8:30am    Welcome (Tasha Woodall & Brock Harris)

8:30-9:30am   Diabetes Update:  Continuous Glucose Monitoring (Cathey Miller)

9:30-10:30am    Diabetes Update:  Drug Updates (Elizabeth Mills)

10:30-10:45am    Break

10:45-11:45am    Choose a Breakout Session

Chronic Care--Palliative Care:  Symptom Management (Cindy Johnston)

or

Health-System--Pharmacogenomics (Amber Frick)

11:45-12:00pm   Transition to Lunch

12:00-1:00pm   Lunch

1:00-1:15   Transition back to Classroom

1:15-2:15pm    Infectious Disease Primer:  UTI, SSTI, & Pneumonia (Bill Hitch)

2:15-2:30pm    Break

2:30-3:30pm    Product Roundtables

3:30-4:30pm    Osteoporosis:  Post-Fracture Care (Mollie Scott)

4:30-5:30pm    Networking Reception 

 

Friday, March 1st

7:30-8:15am    Breakfast and Registration

8:15-9:45am    Debate:  A Lower BP Goal for Older Adults (Irene Ulrich & Kim Nealy)

9:45-10:45am    Pain Management:  Opioid Alternatives (Mackie King)

10:45-11:00am    Break

11:00-12:30pm    Choose a Breakout Session

Chronic Care--Innovative Solutions to Meet Regulatory Requirements (Panel)

Health-System--Mental Health Updates: Depression Treatment Resistant Focus (Chue Lee Black)

12:30-12:45pm   Break & Reset Room for Lunch

12:45-2:30pm    Speaker Lunch (AstraZeneca)

2:30-3:30pm    New Drug Update (Hien Nguyen)

​

Total Available ACPE-Accredited Continuing Education Hours:

 = 10 (5 hours per day)

Friday, March 1

Enjoy lunch with speaker Cathey Miller.Her topic will be The Contribution of the Kidney to the Pathophysiology of Type 2 Diabetes.

Sponsored by AstraZeneca 

Health-System

Administrative/Leadership

Track

Thursday, February 28th 

 

9:30-10:00am   Registration

​

Section I:

Leading Your Most Valuable Resource:  Your People

​

10:00-11:30am    Workforce Resilience:  Developing an Open & Successful Environment (Robert Granko--ConeHealth)

​

11:30-12:00pm    Managing in the 'Me Too' Movement (Katie Sheldon--Mission Hospital)

​

12:00-2:00pm    Lunch & Reverse Showcase with Exhibitors

​

Section II:  

Ensuring Regulatory Compliance, While Managing Operations

​

2:00-2:30pm    Structuring Quality and Regulations into Your Daily Activities (Kuldip Patel--Duke Health)

​

2:30-3:00pm    Developing and Utilizing a 340b Compliance Program (Jami Mann--UNC Medical Center)

​

3:00-3:30pm    Developing and Utilizing a Drug Diversion Prevention Program (Evan Frasure--Duke Health)

​

3:30-4:00pm    Getting Your Organization Ready For USP

800 Compliance (John Valgus--UNC Medical Center)

​

4:00-4:30pm    NCAP Advocacy Update (Penny Shelton)

​

4:30-5:30    Networking Reception

​

Meet Our Speakers

chue black headshot.jpg

Chue Lee Black, PharmD, CPP, BCPS

Educational Session Title: Mental Health Updates with a Focus on Resistant Depression Treatment

Date & Time: Friday, March 1, 2019, 11:00am - 12:30pm

Objectives:

1) Describe the state of mental health in North Carolina

2) Discuss pharmacotherapy strategies for treatment resistant depression

3) Review new psychiatric drug updates

Duke profile picture.jpg

Evan Frasure III, PharmD, BCPS

Educational Session Title: Developing and Utilizing a Drug Diversion Prevention Program

Date & Time: Thursday, February 28, 2019, 3:00pm - 3:30pm

Objectives:

1) Outline the framework needed for a successful drug diversion prevention program

2) Determine next steps for your institution to implement or enhance your drug diversion prevention program

Picture.png

Amber Frick, PharmD, PhD

Educational Session Title: Pharmacogenomics

Date & Time: Thursday, February 28, 2019, 10:45am - 11:45am

Objectives:

1) Define precision medicine, pharmacogenomics, and related nomenclature

2) Apply pharmacogenomics guidelines and resources to patient scenarios

3) Describe successful examples of pharmacogenotyping implemented in hospital and ambulatory care settings and lessons learned

4) Evaluate how pharmacogenomics may affect future clinical practice

download.png

Robert Granko

Educational Session Title: Workforce Resilience: Developing an Open and Successful Environment

Date & Time: Thursday, February 28, 2019, 10:00am - 11:30am

Objectives:

1) Define the signs and symptoms of burnout and understand the difference between burnout versus stress

2) Discover mechanisms to deal with and reframe how you and your team look at those function(s) that are causing burnout

3) Identify ways to reevaluate goals and incorporate de-stressing and burnout tactics to reduce, improve, and recover from burnout and lead a healthier lifestyle toa llow you to flourish

Johnston_Cynthia-2013.jpg

Bill Hitch

Educational Session Title: Infectious Disease Primer: UTI, SSTI, and Pneumonia

Date & Time: Thursday, February 28, 2019, 1:15pm - 2:15pm

Objectives:

1) Assess primary care infectious disease knowledge through interactive trivia game

2) Review infections frequently seen in primary care including urinary tract infections, cellulitis, and pneumonia

3) Explore local patterns of resistance and how to apply to drug therapy decision making

​

​

Cindy Johnston, PharmD, BCPS, CPE

Educational Session Title: Palliative Care: Symptom Management

Date & Time: Thursday, February 28, 2019, 10:45am - 11:45am

Objectives:

1) Discuss use of medications to manage common symptoms of advanced disease

2) Participate in creating a patient-centered pharmacy care plan for a patient with symptom management needs

KING_MACKIE_pharmd_001.jpg

Mackie King, PharmD, BCPS, CPP

Educational Session Title: Pain Management: Opioid Alternatives

Date & Time: Friday, March 1, 2019, 9:45am - 10:45am

Objectives:

1) Assess patients' improvement in pain and function using validated tools

2) Compare risks and benefits of different adjuvant analgesics for a given patient

Create a pain regimen for a patient considering the following factors: description of pain, comorbid conditions, pertinent laboratory values

Todd King

Educational Session Title: Approaches to Meeting Regulatory Requirements

Date & Time: Friday, March 1, 2019, 11:00am - 12:30pm

Objectives:

1) Understanding the pharmacy implications of phase three of the Mega Rule

image002.png

Jami Mann

Educational Session Title: Developing and Utilizing a 340b Compliance Program

Date & Time: Thursday, February 28, 2019, 2:30pm - 3:00pm

Objectives:

1) Identify HRSA 340b Drug Pricing Program requirements

2) Summarize covered entity eligibility and entity type compliance considerations

3) List tools and resources for development of 340b compliance program

4) Describe strategies for utilizing a 340b compliance program

image1.jpg

Cathey Miller

Educational Session Title: Diabetes Update: Continuous Glucose Monitoring

Date & Time: Thursday, February 28, 2019, 8:30am - 9:30am

Objectives:
1) Introduce new CGM technology for management of type 1 and type 2 diabetes

2) Role of professional and personal CGM therapy

3) Use of CGM data in clinical practice

download.jpg

Elizabeth Mills, PharmD, CPP, BCACP, BC-ADM, CDE

Educational Session Title: Diabetes Update: Drug Updates

Date & Time: Thursday, February 28, 2019, 9:30am - 10:30am

Objectives:

1) Recall the dosing, mechanism of action, efficacy, and safety considerations for recently approved medications for the management of diabetes mellitus

2) Explain the clinical impact and role in diabetes management of recently approved medications

3) Select a medication for the management of diabetes for a patient utilizing the American Diabetes Association 2019 Standards of Medical Care treatment algorithm

faculty pic.jpg

Kim Nealy, PharmD, BCPS, CDE, CPP

Educational Session Title: Debate: A Lower BP Goal for Older Adults

Date & Time: Friday, March 1, 2019, 8:15am - 9:45am

Objectives:

1) Evaluate primary literature supporting lower blood pressure goals

2) Describe recommendations for measurement of blood pressure

3) Discuss risks and benefits of aggressive and conservative blood pressure lowering 

4) Identify patient populations who would require more conservative blood pressure lowering

Hien Nguyen_headshot.jpg

Hien Nguyen, PharmD, CPP

Educational Session Title: New Drug Update

Date & Time: Friday, March 1, 2019, 2:00pm - 3:00pm

Objectives:

1) Explain the mechanisms of newly approved FDA medications and their place in therapy

2) Discuss key monitoring parameters and counseling points for these medications

3) Review data available for newly approved medications and compare to current therapies available for similar indications

download.jpg

Kuldip Patel, PharmD

Educational Session Title: Structuring Quality and Regulations into Your Daily Activities

Date & Time: Thursday, February 28, 2019, 2:00pm - 2:30pm

Objectives:

download.jpg

David Phillips

Educational Session Title: Approaches to Meeting Regulatory Requirements

Date & Time: Friday, March 1, 2019, 11:00am - 12:30pm

Objectives:

1) Describe current regulatory and non-regulatory challenges consultant pharmacists face in long-term care facilities.

Mollie Scott, PharmD, BCACP, CPP, FASHP

Educational Session Title: Osteoporosis: Post-Fracture Care

Date & Time: Thursday, February 28, 2019, 3:30pm - 4:30pm

Objectives:

DSC_0610.jpg

Katie Sheldon, PharmD, MS

Educational Session Title: Managing in the #MeToo Movement

Date & Time: Thursday, February 28, 2019, 11:30am - 12:00pm

Objectives:

1) Define the types of sexual harassment

2) Describe the results of research characterizing harassment in the workplace

3) Describe the risks of historical employment practices and methods to turns these risks in to opportunities

download.jpg

Robert Smith, PharmD, BCGP, BCPS, FASCP

Educational Session Title: Workforce Resilience: Developing an Open and Successful Environment

Date & Time: Thursday, February 28, 2019, 10:00am - 11:30am

Objectives:

1) Participants will identify challenges that may negatively impact regulatory compliance

2) Participants will examine strategies that may promote more timely and more consistent adherence to regulatory treatments

download.jpg

Irene Ulrich, PharmD, BCACP, CPP

Educational Session Title: Debate: A Lower BP Goal for Older Adults

Date & Time: Friday, March 1, 2019, 8:15am - 9:45am

Objectives:

1) Evaluate primary literature supporting lower blood pressure goals

2) Describe recommendations for measurement of blood pressure

download-1.jpg

John Valgus

Educational Session Title: Getting Your Organization Ready for USP 800 Compliance

Date & Time: Thursday, February 28, 2019, 3:30pm - 4:00pm

Objectives:

1) Understand key concepts in operationalizing hazardous drug management in compliance with USP<800>

2) Identify controversies and common barriers to achieving best practices in hazardous drug management

bottom of page